This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The societal cost of ischemic stroke is known to be high, an estimated nearly $50 billion (US dollars [USD]) per year in the United States.1 This sum includes the hospitalization for acute care and initial rehabilitation, as well as subsequent clinic appointments, prescriptions, long-term care, and loss of income from inability to work. When policy makers determine acceptability of new stroke therapies, they consider these costs and whether a new therapy offers enough clinical benefit to justify them. However, until now, no one has calculated such long-term costs by levels of disability after stroke, leaving a critical gap in our ability to analyze and compare new therapies. If treatments reduce disability, this may have a substantial impact on the health care system that can then be evaluated next to the cost of widespread use of the intervention.
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
See page 388
- © 2020 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
- Reader response: The enormous financial impact of stroke disability
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
Three-month modified Rankin Scale as a determinant of 5-year cumulative costs after ischemic stroke
The 5-year direct medical cost of neonatal and childhood stroke in a population-based cohort
Short- and Long-term Health Care Resource Utilization and Costs Following Intracerebral Hemorrhage
Health care costs decline after successful epilepsy surgery